Immunomodulatory properties of CNF1 toxin from E. coli: implications for colorectal carcinogenesis

Am J Cancer Res. 2022 Feb 15;12(2):651-660. eCollection 2022.

Abstract

Colorectal cancer (CRC) is a leading cause of cancer death worldwide. The risk of developing CRC is influenced by both environmental and genetic factors. Recently, chronic inflammation and gut microbiota modifications have been associated with increased CRC risk. Escherichia coli belongs to the commensal intestinal flora and can become highly pathogenic following the acquisition of genes coding for virulence factors, such as the cytotoxic necrotizing factor type 1 (CNF1). Numerous reports highlight that, besides exerting direct effects on epithelial cells, CNF1 can also act on immune cells, modulating their responses and possibly contributing to disease development. In the present review, we summarized the key studies addressing the immunomodulatory functions of CNF1 and discussed the contribution that CNF1 can bring about to CRC through the creation of a pro-inflammatory microenvironment.

Keywords: CNF1; Escherichia coli; bacterial toxins; carcinogenesis; colorectal cancer; gut microbiota; immune system; inflammation.

Publication types

  • Review